A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|High Grade Serous Adenocarcinoma of Ovary|Squamous Non-small-cell Lung Cancer|Triple Negative Breast Cancer|Gastric Adenocarcinoma|Colorectal Adenocarcinoma|Esophageal Squamous Cell Carcinoma|Esophageal Adenocarcinoma|Gastroesophageal Junction Adenocarcinoma|Transitional Cell Carcinoma of Bladder|Head and Neck Squamous Cell Carcinoma|Ovarian Carcinosarcoma|Uterine Carcinosarcoma|Uterine Serous Carcinoma|Endometrium Cancer|Chromosomal Instability
Interventions: DRUG: VLS-1488
Sponsor: Volastra Therapeutics, Inc.